Position in PVLA
as of Mar 31, 2026
· filed May 1, 2026
Position Value
$2,486,393
New position
Shares Held
19,947
first reported quarter
Ownership
0.139%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 99.97493357397103.ToString("F0")%
Shared 0.ToString("F0")%
None 0.02506642602897679.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026FIFTH THIRD BANCORP holds $165,893,632 across 150 Biotechnology names. PVLA ranks #17 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
88,499 | $39,518,343 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
34,910 | $26,972,862 | |
| 3 | VCEL |
Vericel Corp
|
256,688 | $8,257,652 | |
| 4 | LCTX |
Lineage Cell Therapeutics, Inc.
|
4,600,000 | $7,268,000 | |
| 5 | TECH |
BIO-TECHNE Corp
|
136,521 | $7,134,587 | |
| 6 | APGE |
Apogee Therapeutics, Inc.
|
63,800 | $5,370,046 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
68,128 | $4,403,112 | |
| 8 | KYMR |
Kymera Therapeutics, Inc.
|
51,238 | $4,267,613 |
All Filings in PVLA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,486,393 | 19,947 | Shares | Defined | 2026-05-01 | |
| No filing history on record for this holder in this stock. | ||||||